Evaluating Zika Virus Pathogenesis in Immunocompromised Mice.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2020
Historique:
entrez: 6 5 2020
pubmed: 6 5 2020
medline: 11 3 2021
Statut: ppublish

Résumé

Mouse models of Zika virus (ZIKV) infection, which recapitulate certain aspects of ZIKV infection in humans, have demonstrated their utility for studying ZIKV pathogenesis and for the initial screening of antivirals, experimental therapeutics, and candidate vaccines for protective efficacy against ZIKV infection. In this chapter we outline the available mouse models and describe the evaluation of ZIKV pathogenesis in an immunocompromised mouse model of ZIKV infection.

Identifiants

pubmed: 32367356
doi: 10.1007/978-1-0716-0581-3_3
doi:

Substances chimiques

Ifnar1 protein, mouse 0
Receptor, Interferon alpha-beta 156986-95-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-40

Auteurs

Bryan D Griffin (BD)

Zoonotic Diseases and Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

David Safronetz (D)

Zoonotic Diseases and Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.

Darwyn Kobasa (D)

Zoonotic Diseases and Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada. darwyn.kobasa@canada.ca.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada. darwyn.kobasa@canada.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH